ATRA vs GILD: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Gilead Sciences Inc in 2026
ATRA
Atara Biotherapeutics Inc
—
GILD
Gilead Sciences Inc
$131.27
Key Metrics Comparison
| Metric | ATRA | GILD | Winner |
|---|---|---|---|
| Market Cap | $87.13M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ATRA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or GILD a better investment?
Comparing ATRA and GILD: Atara Biotherapeutics Inc has a market cap of $87.13M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and GILD?
ATRA (Atara Biotherapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ATRA or GILD?
Both ATRA and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ATRA or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ATRA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $87.13M for ATRA.
Should I buy ATRA or GILD in 2026?
Both ATRA and GILD have investment merit. ATRA trades at $N/A while GILD trades at $131.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and GILD stock?
Key differences: Market Cap ($87.13M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ATRA or GILD in 2026?
The choice between ATRA and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ATRA and GILD?
ATRA (Atara Biotherapeutics Inc) has a market cap of $87.13M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.